Clinical Trials
7
Active:0
Completed:6
Trial Phases
2 Phases
Phase 1:6
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (85.7%)Phase 3
1 (14.3%)A Comparison of PF708 and Forteo in Osteoporosis Patients
Phase 3
Completed
- Conditions
- Osteoporosis
- Interventions
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Pfenex, Inc
- Target Recruit Count
- 181
- Registration Number
- NCT03002428
- Locations
- 🇺🇸
Radiant Research, Puyallup, Washington, United States
🇺🇸The Orthopaedic Group, Mobile, Alabama, United States
🇺🇸SunValley Arthritis Center, Peoria, Arizona, United States
A Comparison Study of PF708 and Forteo in Healthy Subjects
- First Posted Date
- 2016-01-15
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Pfenex, Inc
- Target Recruit Count
- 70
- Registration Number
- NCT02656810
- Locations
- 🇺🇸
Covance Clinical Research Unit, Evansville, Indiana, United States
A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Anthrax
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Pfenex, Inc
- Target Recruit Count
- 54
- Registration Number
- NCT02655549
- Locations
- 🇺🇸
Quintiles Phase One Services, Overland Park, Kansas, United States
Comparison Study of PF530 and Betaferon in Healthy Subjects
Phase 1
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Interferon beta-1b (PF530, Betaferon)
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2015-11-16
- Lead Sponsor
- Pfenex, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT02474134
- Locations
- 🇦🇺
CMAX, Adelaide, South Australia, Australia
Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration
Phase 1
Completed
- Conditions
- Age Related Macular Degeneration (AMD)
- Interventions
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Pfenex, Inc
- Target Recruit Count
- 25
- Registration Number
- NCT02121353
- Locations
- 🇳🇿
Eye Institute, Remuera, Auckland, New Zealand
🇳🇿Auckland Eye 8 St Marks Road Remuera Auckland 1050, Auckland, New Zealand
News
No news found